Abstract
The review contains data concerning breast cancer markers used now in clinical oncology and potential breast cancer markers. Their origin, metabolism, detection methods, potentialities of application for tumour diagnosis, determination of therapy efficiency and prognosis are discussed.
摘要
相似文献
1
[Human breast cancer markers].
Eksp Onkol. 1985;7(4):3-8.
2
[Tissue polypeptide antigen in breast cancer].
Nihon Gan Chiryo Gakkai Shi. 1984 Dec 20;19(10):2287-95.
3
[The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].[肿瘤标志物癌胚抗原、组织多肽抗原、糖类抗原19-9以及铁蛋白和骨钙素在乳腺癌随访研究中的应用]
Wien Klin Wochenschr. 1985 Dec 6;97(23):873-9.
4
[Tumor markers in ovarian cancer].
Jugosl Ginekol Perinatol. 1987 May-Aug;27(3-4):73-5.
5
Usefulness of clinical chemistry measurements in classifying patients with breast cancer.
Crit Rev Clin Lab Sci. 1982;16(4):255-90. doi: 10.3109/10408368209107029.
6
Optimizing tumor markers in breast cancer: monitoring, prognosis, and therapy control.优化乳腺癌肿瘤标志物：监测、预后及治疗控制
Cancer Detect Prev. 1985;8(1-2):35-45.
7
[Immunomorphologic markers in breast cancer].[乳腺癌中的免疫形态学标志物]
Arkh Patol. 1996 Jan-Feb;58(1):6-10.
8
[Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].[4种血清标志物联合检测在各类恶性肿瘤中的优势与局限性]
Minerva Med. 1986 Sep 15;77(34-35):1521-5.
9
Circulating tumor markers in breast cancer (review).乳腺癌中的循环肿瘤标志物（综述）
Anticancer Res. 1990 Jan-Feb;10(1):253-8.
10
[Tissue polypeptide antigen in thyroid cancer].
Nihon Gan Chiryo Gakkai Shi. 1984 Jul 20;19(6):1289-95.
Zotero 插件